Trinity Biotech plc
TRIB · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $52 | $62 | $57 | $104 |
| - Cash | $4 | $5 | $3 | $5 |
| + Debt | $108 | $101 | $94 | $93 |
| Enterprise Value | $156 | $158 | $148 | $192 |
| Revenue | $8 | $16 | $15 | $16 |
| % Growth | -52.2% | 4.7% | -4.4% | – |
| Gross Profit | $2 | $5 | $5 | $6 |
| % Margin | 20.7% | 30.8% | 35% | 36.2% |
| EBITDA | -$6 | -$10 | -$1 | -$4 |
| % Margin | -77.2% | -60.5% | -7.3% | -24.6% |
| Net Income | -$9 | -$17 | -$5 | -$7 |
| % Margin | -116.2% | -106.9% | -31.4% | -42.6% |
| EPS Diluted | -0.48 | -1.2 | -0.46 | -0.71 |
| % Growth | 60% | -160.9% | 35.2% | – |
| Operating Cash Flow | -$3 | $3 | -$4 | -$1 |
| Capital Expenditures | -$0 | -$3 | -$3 | -$3 |
| Free Cash Flow | -$3 | $1 | -$6 | -$4 |